News & Events about Heron Therapeutics Inc.
Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises PR Newswire SAN DIEGO, Jan. 9, 2023 - Preliminary Annual Net Product Sales Across the Company Grew 24% to $106.7 Million in 2022...
Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF and Provision in Newly Passed Congressional Bill Anticipated to Provide Separate Reimbursement Outside of the Packaged Surgical Payment for ZYNRELEF Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF...
Ticker Report
5 months ago
Heron Therapeutics (NASDAQ:HRTX Get Rating) had its target price decreased by Cowen to $5.50 in a research note issued to investors on Monday morning, Stock Target Advisor reports. Several other brokerages have also weighed in on HRTX. Cowen decreased their price objective on Heron ...
Ticker Report
5 months ago
New York State Common Retirement Fund increased its stake in Heron Therapeutics, Inc. (NASDAQ:HRTX Get Rating) by 0.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 807,503 shares of the ...